Search

Your search keyword '"Roobol, Monique J."' showing total 1,733 results
Start Over Author "Roobol, Monique J."
1,733 results on '"Roobol, Monique J."'

204. Screening and prostrate-cancer mortality in a randomized European study

Author

Schroder, Fritz H., Roobol, Monique J., Tammela , Teuvo L.J., Ciatto, Stefano, Hugosson, Jonas, Nelen, Vera, Kwiatkowski, Maciej, Lujan, Marcos, Lilja, Hans, Zappa, Marco, Denis, Louis J., Recker, Franz, Bereguer, Antonio, Maattanen, Liisa, Bangma, Chris H., Aus, Gunnar, Villers, Arnauld, Rebillard, Xavier, van der Kwast, Theodorus, Blinjenberg, Bert G., Moss, Sue M., de Koning, Harry J., and Auvinen, Anssi

Subjects
Mortality -- Control, Mortality -- Prevention, Cancer -- Prevention, Cancer -- Risk factors, Cancer -- Diagnosis, Cancer -- Usage, Cancer -- Health aspects
Abstract

The European randomized study attempts to investigate the efficacy of screening with prostrate-specific-antigen (PSA) on reducing the rate of mortality from prostrate cancer. The results indicate that PSA-based screening was effective in reducing the incidence of mortality by 20%, however, had a high risk of over diagnosis.

Published
2009

206. Secondary Treatment for Men with Localized Prostate Cancer: A Pooled Analysis of PRIAS and ERSPC-Rotterdam Data within the PIONEER Data Platform †.

Author

Beyer, Katharina, Straten, Vera, Remmers, Sebastiaan, MacLennan, Steven, MacLennan, Sara, Gandaglia, Giorgio, Willemse, Peter-Paul M., Herrera, Ronald, Omar, Muhammad Imran, Russell, Beth, Huber, Johannes, Kreuz, Markus, Asiimwe, Alex, Abbott, Tom, Briganti, Alberto, Van Hemelrijck, Mieke, and Roobol, Monique J.

Subjects
PROSTATE cancer patients, GLEASON grading system, RADICAL prostatectomy, WATCHFUL waiting
Abstract

Introduction: Treatment choice for localized prostate cancer is complicated, as each treatment option comes with various pros and cons. It is well established that active surveillance (AS), may be ended with a change to curative treatment at the time of disease progression, but it is less clear whether secondary treatment after initial curative treatment is required. As part of the PIONEER project, we quantified the probabilities of treatment change. Methods: A cohort study based on PRIAS and ERSPC-Rotterdam data was conducted. Patients were followed up for 10 years or until the 31st of December 2017. The primary outcome was the incidence of treatment change following initial treatment (i.e., a change to curative treatment following AS or secondary treatment after initial RP/RT). Results: Over a period of 1 to 5 years after initial treatment, the cumulative incidence of treatment change ranged from 3.8% to 42.8% for AS, from 7.6% to 12.1% for radical prostatectomy (RP) and from no change to 5.3% for radiation therapy (RT). While the possibility of treatment change in AS is known, the numbers within a five-year period were substantial. For RP and RT, the rate of change to secondary treatment was lower, but still non-neglectable, with 5 (10)-year incidences up to 12% (20%) and 5% (16%), respectively. Conclusion: This is one of the first studies comparing the incidence of guideline-recommended treatment changes in men receiving different primary treatments (i.e., AS, RT, or RP) for localized prostate cancer (PCa). [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

208. Impact of cancer screening on metastasis: A prostate cancer case study

Author

Lange, Jane, primary, Remmers, Sebastiaan, additional, Gulati, Roman, additional, Bill-Axelson, Anna, additional, Johansson, Jan-Erik, additional, Kwiatkowski, Maciej, additional, Auvinen, Anssi, additional, Hugosson, Jonas, additional, Hu, Jim C, additional, Roobol, Monique J, additional, Carlsson, Sigrid V, additional, and Etzioni, Ruth, additional

Published
2021
Full Text
View/download PDF

209. IMAGINE—IMpact Assessment of Guidelines Implementation and Education: The Next Frontier for Harmonising Urological Practice Across Europe by Improving Adherence to Guidelines

Author

Cornford, Philip, primary, Smith, Emma Jane, additional, MacLennan, Steven, additional, Pereira-Azevedo, Nuno, additional, Roobol, Monique J., additional, Lumen, Nicolaas, additional, Fullwood, Louise, additional, Duncan, Eilidh, additional, Dunsmore, Jennifer, additional, Plass, Karin, additional, Ribal, Maria J., additional, Knoll, Thomas, additional, Bjartell, Anders, additional, Van Poppel, Hendrick, additional, N’Dow, James, additional, Briganti, Alberto, additional, Dorfinger, Karl, additional, Resch, Irene, additional, Johannes, Mischinger, additional, Heidegger, Isabel, additional, Assenmacher, Christophe, additional, Roumeguère, Thierry, additional, Decaestecker, Karel, additional, Goeman, Lieven, additional, Adams, Thomas, additional, Georgiev, Marincho, additional, Yanev, Krassimir, additional, Timev, Aleksandar, additional, Tomašković, Igor, additional, Kuliš, Tomislav, additional, Charalampous, Stavros, additional, Kontaxis, Dimitris, additional, Babjuk, Marko, additional, Zachoval, Roman, additional, Pitra, Tomáš, additional, Novák, Vojtěch, additional, Lund, Lars, additional, Kivi, Martin, additional, Baum, Peep, additional, Tamm, Toomas, additional, Veskimae, Pritt, additional, Okas, Rauno, additional, Lahdensuo, Kanerva, additional, Taari, Kimmo, additional, Seikkula, Heikki, additional, Jämsä, Pyry, additional, Gamé, Xavier, additional, Fournier, George, additional, Ingels, Alexandre, additional, Fiard, Gaelle, additional, Ploussard, Guillaume, additional, Rassweiler, Jens, additional, Schmidt, Stefanie, additional, Kranz, Jennifer, additional, Krege, Susanne, additional, Gkialas, Ioannis, additional, Dellis, Anthanasios, additional, Ferakis, Nikolaos, additional, Mitropoulos, Dionysios, additional, Ryan, Peter, additional, Sweeney, John Paul, additional, Rogers, Eamonn, additional, Hennessy, Derek, additional, Davis, Niall. F., additional, Artibani, Walter, additional, Porpiglia, Francesco, additional, Giuseppe Voce, Salvatore, additional, Brausi, Maurizio, additional, Cerruto, Maria A., additional, Esperto, Francesco, additional, Manfredi, Matteo, additional, Jievaltas, Mindaugas, additional, Patašius, Aušvydas, additional, Čekauskas, Albertas, additional, Auškalnis, Stasys, additional, Mulders, Peter, additional, Martens, Frank, additional, D'Hauwers, Kathleen W.M., additional, Chlosta, Piotr, additional, Katarzyna Czech, Anna, additional, Gronostaj, Katarzyna, additional, Przydacz, Mikołaj, additional, Coelho Nunes, Pedro, additional, Abranches-Monteiro, Luís, additional, Pereira e Silva, Ricardo, additional, Furriel, Frederica, additional, Gomes Monteiro, Pedro, additional, Sinescu, Ioanel, additional, Surcel, Cristian, additional, Baston, Catalin, additional, Ionut Stoica, Robert, additional, Olaru, Vlad, additional, Kollárik, Boris, additional, Mincik, Ivan, additional, Rybár, Ľuboš, additional, Kováčik, Viktor, additional, Perečinský, Ivan, additional, Kosuta, Boris, additional, Zupancic, Marko, additional, Taskovska, Milena, additional, Kacjan, Uros, additional, Miklavzina, Andraz, additional, Esteban Fuertes, Manuel, additional, Alvarez-Maestro, Mario, additional, Vilaseca, Antoni, additional, García-Baquero, Rodrigo, additional, Renström Koskela, Lotta, additional, Styrke, Johan, additional, Galiqi, Gezim, additional, Hoxha, Bilbil, additional, Zhapa, Evisa, additional, Xhani, Rezart, additional, Fanarjyan, Sergey, additional, Hovhannisyan, Ruben, additional, Armen, Avoyan E., additional, Badalyan, Rafael, additional, Hiroš, Mustafa, additional, Tomić, Davor, additional, Aganović, Damir, additional, Chkhotua, Archil, additional, Nikoleishvili, David, additional, Tchanturaia, Zara, additional, Gudjónsson, Sigurdur, additional, Orri Gudmundsson, Eirikur, additional, Hilmarsson, Rafn, additional, Ceban, Emil, additional, Ghicavii, Vitalii, additional, Tanase, Adrian, additional, Vasiliev, Vladislav, additional, Perovic, Dragoljub, additional, Vukovic, Marko, additional, Rade, Stanisavljevic, additional, Radovic, Nenad, additional, Nasufovic, Emil, additional, Alyaev, Yuri, additional, Korneyev, Igor, additional, Kotov, Sergei, additional, Malkhasyan, Vigen, additional, Basic, Dragoslav, additional, Aćimović, Miodrag, additional, Vojinov, Saša, additional, Vuksanovic, Aleksandar, additional, Bumbaširević, Uroš, additional, Čegar, Bojan, additional, Stanković, Branko, additional, Danuser, Hansjörg, additional, Sulser, Tullio, additional, Zumstein, Valentin, additional, Kadioglu, Ates, additional, Kilicarslan, Hakan, additional, Can Cilesiz, Nusret, additional, Demirelli, Erhan, additional, Önal, Bülent, additional, Mungan, Aydin, additional, Tekgül, Serdar, additional, Türkeri, Levent, additional, Esen, Adil, additional, Shulyak, Oleksandr, additional, Vozianov, Sergiy, additional, Shulyak, Alexandr, additional, Volkov, Serhii, additional, and Nesterchuk, Andrii, additional

Published
2021
Full Text
View/download PDF

211. Genomic analysis of male puberty timing highlights shared genetic basis with hair colour and lifespan

Author

Hollis, Ben, Day, Felix R., Busch, Alexander S., Thompson, Deborah J., Soares, Ana Luiza G., Timmers, Paul R. H. J., Kwong, Alex, Easton, Doug F., Joshi, Peter K., Timpson, Nicholas J., Ong, Ken K., Perry, John R. B., Eeles, Rosalind A., Henderson, Brian E., Haiman, Christopher A., Kote-Jarai, Zsofia, Schumacher, Fredrick R., Olama, Ali Amin Al, Benlloch, Sara, Muir, Kenneth, Berndt, Sonja I., Conti, David V., Wiklund, Fredrik, Chanock, Stephen, Gapstur, Susan, Stevens, Victoria L., Tangen, Catherine M., Batra, Jyotsna, Clements, Judith, Gronberg, Henrik, Pashayan, Nora, Schleutker, Johanna, Albanes, Demetrius, Wolk, Alicja, West, Catharine, Mucci, Lorelei, Cancel-Tassin, Géraldine, Koutros, Stella, Sorensen, Karina Dalsgaard, Grindedal, Eli Marie, Neal, David E., Hamdy, Freddie C., Donovan, Jenny L., Travis, Ruth C., Hamilton, Robert J., Ingles, Sue Ann, Rosenstein, Barry S., Lu, Yong-Jie, Giles, Graham G., Kibel, Adam S., Vega, Ana, Kogevinas, Manolis, Penney, Kathryn L., Park, Jong Y., Stanford, Janet L., Cybulski, Cezary, Nordestgaard, Børge G., Brenner, Hermann, Maier, Christiane, Kim, Jeri, John, Esther M., Teixeira, Manuel R., Neuhausen, Susan L., De Ruyck, Kim, Razack, Azad, Newcomb, Lisa F., Lessel, Davor, Kaneva, Radka, Usmani, Nawaid, Claessens, Frank, Townsend, Paul A., Gago-Dominguez, Manuela, Roobol, Monique J., Menegaux, Florence, Khaw, Kay-Tee, Cannon-Albright, Lisa, Pandha, Hardev, Thibodeau, Stephen N., Tilley, Wayne, Risbridger, Gail P., Horvath, Lisa, Taylor, Renea, Hayes, Vanessa, Butler, Lisa, Yeadon, Trina, Eckert, Allison, Saunders, Pamela, Haynes, Anne-Maree, Papargiris, Melissa, Srinivasan, Srilakshmi, Kedda, Mary-Anne, Moya, Leire, Agee, Michelle, Alipanahi, Babak, Auton, Adam, Bell, Robert K., Bryc, Katarzyna, Elson, Sarah L., Fontanillas, Pierre, Furlotte, Nicholas A., Hinds, David A., Huber, Karen E., Kleinman, Aaron, Litterman, Nadia K., McIntyre, Matthew H., Mountain, Joanna L., Noblin, Elizabeth S., Northover, Carrie A. M., Pitts, Steven J., Sathirapongsasuti, J. Fah, Sazonova, Olga V., Shelton, Janie F., Shringarpure, Suyash, Tian, Chao, Tung, Joyce Y., Vacic, Vladimir, Wilson, Catherine H., Day, Felix R. [0000-0003-3789-7651], Busch, Alexander S. [0000-0003-4417-569X], Thompson, Deborah J. [0000-0003-1465-5799], Soares, Ana Luiza G. [0000-0003-2763-4647], Timmers, Paul R. H. J. [0000-0002-5197-1267], Kwong, Alex [0000-0003-1953-2771], Easton, Doug F. [0000-0003-2444-3247], Joshi, Peter K. [0000-0002-6361-5059], Timpson, Nicholas J. [0000-0002-7141-9189], Ong, Ken K. [0000-0003-4689-7530], and Apollo - University of Cambridge Repository

Subjects
631/443/494, 631/208/205/2138, 692/308/2056, 45/43, article, 692/163
Abstract

The timing of puberty is highly variable and is associated with long-term health outcomes. To date, understanding of the genetic control of puberty timing is based largely on studies in women. Here, we report a multi-trait genome-wide association study for male puberty timing with an effective sample size of 205,354 men. We find moderately strong genomic correlation in puberty timing between sexes (rg = 0.68) and identify 76 independent signals for male puberty timing. Implicated mechanisms include an unexpected link between puberty timing and natural hair colour, possibly reflecting common effects of pituitary hormones on puberty and pigmentation. Earlier male puberty timing is genetically correlated with several adverse health outcomes and Mendelian randomization analyses show a genetic association between male puberty timing and shorter lifespan. These findings highlight the relationships between puberty timing and health outcomes, and demonstrate the value of genetic studies of puberty timing in both sexes.

Published
2020

215. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

Author

Kasivisvanathan, Veeru, Rannikko, Antti S, Borghi, Marcelo, Panebianco, Valeria, Mynderse, Lance A, Vaarala, Markku H, Briganti, Alberto, Budäus, Lars, Hellawell, Giles, Hindley, Richard G, Roobol, Monique J, Eggener, Scott, Ghei, Maneesh, Villers, Arnauld, Bladou, Franck, Villeirs, Geert M, Virdi, Jaspal, Boxler, Silvan, Robert, Grégoire, Singh, Paras B, Venderink, Wulphert, Hadaschik, Boris A, Ruffion, Alain, Jim C, Hu, Margolis, Daniel, Crouzet, Sébastien, Klotz, Laurence, Taneja, Samir S, Pinto, Peter, Gill, Inderbir, Allen, Clare, Giganti, Francesco, Freeman, Alex, Morris, Stephen, Punwani, Shonit, Williams, Norman R, Brew-Graves, Chris, Deeks, Jonathan, Takwoingi, Yemisi, Emberton, Mark, Moore, Caroline M, Precision, Study Group Collaborators, Catalano, Carlo, Leonardo, Costantino, Sciarra, Alessandro, Grompone, Marcello Domenico, Del Monte, Maurizio, D'Eramo, Giuseppe, Salvo, Vincenzo, Campa, Riccardo, Urology, Kasivisvanathan, V., Rannikko, A. S., Borghi, M., Panebianco, V., Mynderse, L. A., Vaarala, M. H., Briganti, A., Budäus, L., Hellawell, G., Hindley, R. G., Roobol, M. J., Eggener, S., Ghei, M., Villers, A., Bladou, F., Villeirs, G. M., Virdi, J., Boxler, S., Robert, G., Singh, P. B., Venderink, W., Hadaschik, B. A., Ruffion, A., Hu, J. C., Margolis, D., Crouzet, S., Klotz, L., Taneja, S. S., Pinto, P., Gill, I., Allen, C., Giganti, F., Freeman, A., Morris, S., Punwani, S., Williams, N. R., Brew-Graves, C., Deeks, J., Takwoingi, Y., Emberton, M., Moore, C. M., and for the PRECISION Study Group, Collaborators

Subjects
Male, fusion, Intention to Treat Analysi, Cost effectiveness, Biopsy, 030232 urology & nephrology, Medizin, outcomes, Prostate cancer, 0302 clinical medicine, Surveys and Questionnaire, 610 Medicine & health, medicine.diagnostic_test, Medicine (all), Prostate, magnetic-resonance, General Medicine, Middle Aged, Magnetic Resonance Imaging, PI-RADS, 030220 oncology & carcinogenesis, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Radiology, Human, Quality Control, medicine.medical_specialty, men, Risk Assessment, ultrasound-guided biopsy, active surveillance, cost-effectiveness, Follow-Up Studie, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, SDG 3 - Good Health and Well-being, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], medicine, Ultrasonography, Interventional, Aged, Intention-to-treat analysis, business.industry, Cancer, Magnetic resonance imaging, medicine.disease, Prostatic Neoplasm, Quality of Life, Ultrasound-Guided Biopsy, business
Abstract

BACKGROUND: Multiparametric magnetic resonance imaging (MRI), with or without targeted biopsy, is an alternative to standard transrectal ultrasonography-guided biopsy for prostate-cancer detection in men with a raised prostate-specific antigen level who have not undergone biopsy. However, comparative evidence is limited. METHODS: In a multicenter, randomized, noninferiority trial, we assigned men with a clinical suspicion of prostate cancer who had not undergone biopsy previously to undergo MRI, with or without targeted biopsy, or standard transrectal ultrasonography-guided biopsy. Men in the MRI-targeted biopsy group underwent a targeted biopsy (without standard biopsy cores) if the MRI was suggestive of prostate cancer; men whose MRI results were not suggestive of prostate cancer were not offered biopsy. Standard biopsy was a 10-to-12-core, transrectal ultrasonography-guided biopsy. The primary outcome was the proportion of men who received a diagnosis of clinically significant cancer. Secondary outcomes included the proportion of men who received a diagnosis of clinically insignificant cancer. RESULTS: A total of 500 men underwent randomization. In the MRI-targeted biopsy group, 71 of 252 men (28%) had MRI results that were not suggestive of prostate cancer, so they did not undergo biopsy. Clinically significant cancer was detected in 95 men (38%) in the MRI-targeted biopsy group, as compared with 64 of 248 (26%) in the standard-biopsy group (adjusted difference, 12 percentage points; 95% confidence interval [CI], 4 to 20; P = 0.005). MRI, with or without targeted biopsy, was noninferior to standard biopsy, and the 95% confidence interval indicated the superiority of this strategy over standard biopsy. Fewer men in the MRI-targeted biopsy group than in the standard-biopsy group received a diagnosis of clinically insignificant cancer (adjusted difference, -13 percentage points; 95% CI, -19 to -7; P

Published
2018

217. Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN

Author

Hirama, Hiromi, primary, Sugimoto, Mikio, additional, Miyatake, Nobuyuki, additional, Kato, Takuma, additional, Venderbos, Lionne D. F., additional, Remmers, Sebastiaan, additional, Shiga, Kenichiro, additional, Yokomizo, Akira, additional, Mitsuzuka, Koji, additional, Matsumoto, Ryuji, additional, Osawa, Takahiro, additional, Abe, Takashige, additional, Sasaki, Hiroshi, additional, Egawa, Shin, additional, Ninomiya, Iku, additional, Hashine, Katsuyoshi, additional, Roobol, Monique J., additional, and Kakehi, Yoshiyuki, additional

Published
2020
Full Text
View/download PDF

229. Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients.

Author

Seyrek, Neslisah, Hollemans, Eva, Osanto, Susanne, Pelger, Rob C M, van der Poel, Henk G, Bekers, Elise, Bangma, Chris H, Rietbergen, John, Roobol, Monique J, Schoots, Ivo G, and van Leenders, Geert J L H

Subjects
PROSTATE cancer patients, RADICAL prostatectomy, PERCENTILES
Abstract

Aims: Gleason pattern 4 (GP4) percentage, invasive cribriform and/or intraductal carcinoma (IC/IDC) and the presence of tertiary Gleason pattern 5 (TP5) in radical prostatectomy (RP) specimens all aid in the risk stratification of Grade Group (GG) 2 prostate cancer patients. However, it is unclear to what extent these pathological features are mutually related and what are their individual values if they are investigated simultaneously. The aims of this study were: (i) to determine the mutual relationships of the GP4 percentage, IC/IDC and TP5 in GG2 RP specimens; and (ii) to assess their prognostic value for biochemical recurrence‐free survival (BCRFS). Methods and results: Of 1064 RP specimens, 472 (44.4%) showed GG2 prostate cancer. Patients with ≥25% GP4 more frequently had IC/IDC (67.0% versus 43.9%; P < 0.001) and TP5 (20.6% versus 5.8%; P < 0.001) than those with <25% GP4. In unadjusted analysis, an increased GP4 percentage [hazard ratio (HR) 1.3; 95% confidence interval (CI) 1.0–1.6; P = 0.04] and IC/IDC (log rank P < 0.001) were associated with shorter BCRFS, whereas TP5 (P = 0.12) and a dichotomised (<25%, ≥25%) GP4 percentage (P = 0.10) were not. In multivariable analysis, IC/IDC was an independent prognostic factor (HR 1.9; 95% CI 1.2–2.9; P = 0.005) for BCRFS, whereas a continuous or dichotomised GP4 percentage and TP5 were not independent prognostic factors. Conclusion: In conclusion, a higher GP4 percentage in RP specimens was associated with more frequent IC/IDC and TP5. IC/IDC was an independent predictor for BCRFS, whereas the GP4 percentage and TP5 were not. These findings underscore the importance of routinely including the presence of IC/IDC in RP pathology reports. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

233. Quality-of-Life Effects of Prostate-Specific Antigen Screening

Author

Heijnsdijk, Eveline A.M., Wever, Elisabeth M., Auvinen, Anssi, Hugosson, Jonas, Ciatto, Stefano, Nelen, Vera, Kwiatkowski, Maciej, Villers, Arnauld, Páez, Alvaro, Moss, Sue M., Zappa, Marco, Tammela, Teuvo L.J., Mäkinen, Tuukka, Carlsson, Sigrid, Korfage, Ida J., Essink-Bot, Marie-Louise, Otto, Suzie J., Draisma, Gerrit, Bangma, Chris H., Roobol, Monique J., Schröder, Fritz H., and de Koning, Harry J.

Published
2012

238. Prostate-Cancer Mortality at 11 Years of Follow-up

Author

Schröder, Fritz H., Hugosson, Jonas, Roobol, Monique J., Tammela, Teuvo L.J., Ciatto, Stefano, Nelen, Vera, Kwiatkowski, Maciej, Lujan, Marcos, Lilja, Hans, Zappa, Marco, Denis, Louis J., Recker, Franz, Páez, Alvaro, Määttänen, Liisa, Bangma, Chris H., Aus, Gunnar, Carlsson, Sigrid, Villers, Arnauld, Rebillard, Xavier, van der Kwast, Theodorus, Kujala, Paula M., Blijenberg, Bert G., Stenman, Ulf-Hakan, Huber, Andreas, Taari, Kimmo, Hakama, Matti, Moss, Sue M., de Koning, Harry J., and Auvinen, Anssi

Published
2012

243. Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies

Author

van der Kwast, Theo H., Helleman, Jozien, Nieboer, Daan, Bruinsma, Sophie M., Roobol, Monique J., Trock, Bruce, Ehdaie, Behfar, Carroll, Peter, Filson, Christopher, Kim, Jeri, Logothetis, Christopher, Morgan, Todd, Klotz, Laurence, Pickles, Tom, Hyndman, Eric, Moore, Caroline M., Gnanapragasam, Vincent, Van Hemelrijck, Mieke, Dasgupta, Prokar, Bangma, Chris, Roobol, Monique, Villers, Arnauld, Rannikko, Antti, Valdagni, Riccardo, Perry, Antoinette, Hugosson, Jonas, Rubio-Briones, Jose, Bjartell, Anders, Hefermehl, Lukas, Shiong, Lee Lui, Frydenberg, Mark, Kakehi, Yoshiyuki, Chung, Byung Ha, van der Kwast, Theo, Obbink, Henk, van der Linden, Wim, Hulsen, Tim, de Jonge, Cees, Kattan, Mike, Xinge, Ji, Muir, Kenneth, Lophatananon, Artitaya, Fahey, Michael, Steyerberg, Ewout, Zhang, Liying, Guo, Wei, Benfante, Nicole, Cowan, Janet, Patil, Dattatraya, Tolosa, Emily, Kim, Tae-Kyung, Mamedov, Alexandre, LaPointe, Vincent, Crump, Trafford, Kimberly-Duffell, Jenna, Santaolalla, Aida, Olivier, Jona-than, Rancati, Tiziana, Ahlgren, Helén, Mascarós, Juanma, Löfgren, Annica, Lehmann, Kurt, Lin, Catherine Han, Hirama, Hiromi, Lee, Kwang Suk, Jenster, Guido, Auvinen, Anssi, Haider, Masoom, van Bochove, Kees, Carter, Ballentine, Gledhill, Sam, Buzza, Mark, and Bruinsma, Sophie

Published
2019
Full Text
View/download PDF

249. Intraoperative assessment and reporting of radical prostatectomy specimens to guide nerve‐sparing surgery in prostate cancer patients (NeuroSAFE)

Author

Slot, Margaretha A, primary, Bakker, Michael A, additional, Klaver, Sjoerd, additional, Kliffen, Mike, additional, Busstra, Martijn B, additional, Rietbergen, John B W, additional, Gan, Melanie, additional, Hamoen, Karen E, additional, Budel, Leo M, additional, Goemaere, Natascha N T, additional, Bangma, Chris H, additional, Helleman, Jozien, additional, Roobol, Monique J, additional, and Leenders, Geert J L H, additional

Published
2020
Full Text
View/download PDF

250. Optimal Timing of Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography for Biochemical Recurrence after Radical Prostatectomy

Author

Luiting, Henk B., primary, van Leeuwen, Pim J., additional, Remmers, Sebastiaan, additional, Donswijk, Maarten, additional, Busstra, Martijn B., additional, Bakker, Ingrid L., additional, Brabander, T., additional, Stokkel, Marcel, additional, van der Poel, Henk G., additional, and Roobol, Monique J., additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results